Biosten, a Skolkovo resident startup, presented the technology of radiopaque coating based on lanthanum-containing microparticles at the Fundamental Research and Innovations for Endovascular Surgery 2018 conference on April 12. The event, organized by the N...
Quantitative modeling researchers from M&S Decisions, a Skolkovo member company, presented at a scientific seminar on innovative methods in drug development held on October 17, 2016 at the U.S. Food and Drug Administration (FDA) in Washington D.C. ...
The Skolkovo Foundation will participate in 2014 BIO International Convention, the international biotechnology exhibition, which will take place in San Diego, USA on 23-26 June 2014. As the world’s largest biotechnology gathering BIO 2014 will bring together...
Since 3-5 June, 2014 in Finland (Turku city) was conducted Baltic Sea Health Summit – the biggest forum in pharmaceutical, biotechnology and medical industries in Baltic Sea countries ( www.bshs.eu ). The Health Forum was organized under the umbrella...
OncoMax presented its research results at the 5 th European Multidisciplinary Meeting on Urological Cancers (EMUC) which was held in Marseille, France on 15-17 November 2013. Dr. Ilya Tsimafeyev, Scientific Advisor of Oncomax, won the First Prize for...
OncoMax presented the results of its research in the field of onco-urologic diseases at the 27 th Annual Congress of the European Association of Urologists taking place in Paris during February 24-28. Based on the research results measuring the effectiveness...
On 5–7 December, Skolkovo companies representing the biomedicine , IТ , energy efficiency clusters visited Berlin where they got acquainted with the innovation infrastructure. They visited the largest technopark Adlershof and the biomedical technopark...
The Skolkovo Fund has approved a $5m grant to TheraMAB, innovation and venture news source UNOVA reports. The money will be reportedly spent on development of a medicine that can selectively modulate activity of T-lymphocytes for treating rheumatoid arthritis...
Eagle Genomics are conducting a second survey of current issues in operational bioinformatics. We build on the success of last year's survey which polled over 100 worldwide responses from both industry and academia. A report detailing the results of...